High expression of stathmin protein predicts a fulminant course in medulloblastoma: Clinical article

Journal of Neurosurgery: Pediatrics

Volumn 4, Issue 1, 2009, Pages 74-80

  Kuo, Meng Fai ^a,b   Wang, Huei Shyong ^c   Kuo, Quang Ting ^a   Shun, Chia Tung ^a   Hsu, Hey Chi ^a   Yang, Shih Hong ^a   Yuan, Ray Hwang ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Brain neoplasm; Medulloblastoma; Prognosis; Stathmin

Indexed keywords

KI 67 ANTIGEN; STATHMIN;

ADOLESCENT; ADULT; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CEREBROSPINAL FLUID CYTOLOGY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MEDULLOBLASTOMA; METASTASIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SCHOOL CHILD; TUMOR BIOPSY; TUMOR CELL; TUMOR GROWTH;

AGE FACTORS; CEREBELLAR NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEDULLOBLASTOMA; PROGNOSIS; SEX FACTORS; STATHMIN; UP-REGULATION;

EID: 67650115359     PISSN: 19330707     EISSN: 19330715     Source Type: Journal    
DOI: 10.3171/2009.2.PEDS08287     Document Type: Article

References (44)

1. Alaiya AA, Franzén B, Fujioka K, Moberger B, Schedvins K, Silfversvärd C, et al: Phenotypic analysis of ovarian carcinoma: polypeptide expression in benign, borderline and malignant tumors. Int J Cancer 73:678-683, 1997 (Pubitemid 127483063)
2. Albright AL: Medulloblastoma, in Albright AL, Pollack IF, Adelson PD (eds): Principles and Practice of Pediatric Neurosurgery. New York: Thieme, 1999, pp 591-608
3. Albright AL, Wisoff JH, Zeltzer PM, Boyett JM, Rorke LB, Stanley P: Effects of medulloblastoma resections on outcome in children: a report from the Children's Cancer Group. Neurosurgery 38:265-271, 1996 (Pubitemid 26030705)
4. Bayani J, Zielenska M, Marrano P, Kwan NY, Taylor MD, Jay V, et al: Molecular cytogenetic analysis of medulloblastomas and supratentorial primitive neuroectodermal tumors by using conventional banding, comparative genomic hybridization, and spectral karyotyping. J Neurosurg 93:437-448, 2000 (Pubitemid 30677207)
5. Belletti B, Nicoloso MS, Schiappacassi M, Berton S, Lovat F, Wolf K, et al: Stathmin activity influences sarcoma cell shape, motility, and metastatic potential. Mol Biol Cell 19:2003-2013, 2008
6. Belmont LD, Mitchison TJ: Identification of a protein that interacts with tubulin dimers and increases the catastrophe rate of microtubules. Cell 84:623-631, 1996 (Pubitemid 26071742)
7. Brattsand G: Correlation of oncoprotein 18/stathmin expression in human breast cancer with established prognostic factors. Br J Cancer 83:311-318, 2000 (Pubitemid 30453569)
8. Cassimeris L: Accessory protein regulation of microtubule dynamics throughout the cell cycle. Curr Opin Cell Biol 11:134-141, 1999 (Pubitemid 29084142)
9. Cassimeris L: The oncoprotein 18/stathmin family of microtubule destabilizers. Curr Opin Cell Biol 14:18-24, 2002 (Pubitemid 34131652)
10. Chang CH, Housepian EM, Herbert C: An operative staging system and a megavoltage radiotherapeutic technique for cerebellar medulloblastoma. Radiology 93:1351-1359, 1969
11. Curmi PA, Gavet O, Charbaut E, Ozon S, Lachkar-Colmerauer S, Manceau V, et al: Stathmin and its phosphoprotein family: general properties, biochemical and functional interaction with tubulin. Cell Struct Funct 24:345-357, 1999
12. Desai A, Mitchison TJ: Microtubule polymerization dynamics. Annu Rev Cell Dev Biol 13:83-117, 1997
13. Ellison D: Classifying the medulloblastoma: insights from morphology and molecular genetics. Neuropathol Appl Neurobiol 28:257-282, 2002
14. Feuerstein N, Cooper HL: Rapid protein phosphorylation induced by phorbol ester in HL-60 cells. Unique alkali-stable phosphorylation of a 17,000-dalton protein detected by two-dimensional gel electrophoresis. J Biol Chem 258:10786-10793, 1983 (Pubitemid 14244344)
15. Friedrich B, Grönberg H, Landström M, Gullberg M, Bergh A: Differentiation-stage specific expression of oncoprotein 18 in human and rat prostatic adenocarcinoma. Prostate 27:102-109, 1995
16. Gajjar A, Hernan R, Kocak M, Fuller C, Lee Y, McKinnon PJ, et al: Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma. J Clin Oncol 22:984-993, 2004 (Pubitemid 41095029)
17. Grotzer MA, Janss AJ, Fung K, Biegel JA, Sutton LN, Rorke LB, et al: TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors. J Clin Oncol 18: 1027-1035, 2000 (Pubitemid 30123779)
18. Guessous F, Li Y, Abounader R: Signaling pathways in medulloblastoma. J Cell Physiol 217:577-583, 2008
19. Hailat N, Strahler J, Melhem R, Zhu XX, Brodeur G, Seeger RC, et al: N-myc gene amplification in neuroblastoma is associated with altered phosphorylation of a proliferation related polypeptide (Op18). Oncogene 5:1615-1618, 1990 (Pubitemid 120034680)
20. Hanash SM, Strahler JR, Kuick R, Chu EH, Nichols D: Identification of a polypeptide associated with the malignant phenotype in acute leukemia. J Biol Chem 263:12813-12815, 1988 (Pubitemid 18238335)
21. Hsu HC, Jeng YM, Mao TL, Chu JS, Lai PL, Peng SY: Betacatenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis. Am J Pathol 157:763-770, 2000 (Pubitemid 32109369)
22. Hyman AA, Karsenti E: Morphogenetic properties of microtubules and mitotic spindle assembly. Cell 84:401-410, 1996 (Pubitemid 26058565)
23. Jeha S, Luo XN, Beran M, Kantarjian H, Atweh GF: Antisense RNA inhibition of phosphoprotein p18 expression abrogates the transformed phenotype of leukemic cells. Cancer Res 56: 1445-1450, 1996 (Pubitemid 26080992)
24. Jin K, Mao XO, Cottrell B, Schilling B, Xie L, Row RH, et al: Proteomic and immunochemical characterization of a role for stathmin in adult neurogenesis. FASEB J 18:287-299, 2004 (Pubitemid 38186248)
25. Korshunov A, Benner A, Remke M, Lichter P, von Deimling A, Pfister S: Accumulation of genomic aberrations during clinical progression of medulloblastoma. Acta Neuropathol 116:383-390, 2008
26. Laurent JP, Chang CH, Cohen ME: A classification for primitive neuroectodermal tumors (medulloblastoma) of the posterior fossa. Cancer 56:1807-1809, 1985 (Pubitemid 16218930)
27. Luo XN, Arcasoy MO, Brickner HE, Mistry S, Schechter AD, Atweh GF: Regulate expression of p18, a major phosphoprotein of leukemic cells. J Biol Chem 266:21004-21010, 1991 (Pubitemid 21908565)
28. Mistry SJ, Bank A, Atweh GF: Synergistic antiangiogenic effects of stathmin inhibition and taxol exposure. Mol Cancer Res 5:773-782, 2007 (Pubitemid 47294805)
29. Neben K, Korshunov A, Benner A, Wrobel G, Hahn M, Koko cinski F, et al: Microarray-based screening for molecular markers in medulloblastoma revealed STK15 as independent predictor for survival. Cancer Res 64:3103-3111, 2004 (Pubitemid 38581410)
30. Niethammer P, Bastiaens P, Karsenti E: Stathmin-tubulin interaction gradients in motile and mitotic cells. Science 303: 1862-1866, 2004 (Pubitemid 38374877)
31. Nishio K, Nakamura T, Koh Y, Kanzawa F, Tamura T, Saijo N: Oncoprotein 18 overexpression increases the sensitivity to vindesine in the human lung carcinoma cells. Cancer 91:1494-1499, 2001 (Pubitemid 32319260)
32. Nylander K, Marklund U, Brattsand G, Gullberg M, Roos G: Immunohistochemical detection of oncoprotein 18 (Op18) in malignant lymphomas. Histochem J 27:155-160, 1995
33. Packer RJ, Rood BR, MacDonald TJ: Medulloblastoma: present concepts of stratification into risk groups. Pediatr Neurosurg 39:60-67, 2003 (Pubitemid 36829097)
34. Riabowol K, Draetta G, Brizuela L, Vandre D, Beach D: The cdc2 kinase is a nuclear protein that is essential for mitosis in mammalian cells. Cell 57:393-401, 1989 (Pubitemid 19126273)
35. Roos G, Brattsand G, Landberg G, Marklund U, Gullberg M: Expression of oncoprotein 18 in human leukemias and lymphomas. Leukemia 7:1538-1546, 1993 (Pubitemid 23319129)
36. Rubin CI, Atweh GF: The role of stathmin in the regulation of the cell cycle. J Cell Biochem 93:242-250, 2004 (Pubitemid 44264202)
37. Sanders RP, Onar A, Boyett JM, Broniscer A, Morris EB, Qaddoumi I, et al: M1 Medulloblastoma: high risk at any age. J Neurooncol 90:351-355, 2008
38. Shim KW, Joo SY, Kim SH, Choi JU, Kim DS: Prediction of prognosis in children with medulloblastoma by using immunohistochemical analysis and tissue microarray. J Neurosurg Pediatr 1:196-205, 2008 (Pubitemid 351346508)
39. Singer S, Ehemann V, Brauckhoff A, Keith M, Vreden S, Schirmacher P, et al: Protumorigenic overexpression of stathmin/ Op18 by gain-of-function mutation in p53 in human hepatocarcinogenesis. Hepatology 46:759-768, 2007 (Pubitemid 47436122)
40. Takahashi M, Yang XJ, Lavery TT, Furge KA, Williams BO, Tretiakova M, et al: Gene expression profiling of favorable histology Wilms tumors and its correlation with clinical features. Cancer Res 62:6598-6605, 2002 (Pubitemid 35364126)
41. Walczak CE, Mitchison TJ, Desai A: XKCM1: a Xenopus kinesin-related protein that regulates microtubule dynamics during mitotic spindle assembly. Cell 84:37-47, 1996 (Pubitemid 26031459)
42. Wei SH, Lin F, Wang X, Gao P, Zhang HZ: Prognostic significance of stathmin expression in correlation with metastasis and clinicopathological characteristics in human ovarian carcinoma. Acta Histochem 110:59-65, 2008
43. Yuan RH, Jeng YM, Chen HL, Lai PL, Pan HW, Hsieh FJ, et al: Stathmin overexpression cooperates with p53 mutation and osteopontin overexpression, and is associated with tumour progression, early recurrence, and poor prognosis in hepatocellular carcinoma. J Pathol 209:549-558, 2006 (Pubitemid 44194570)
44. Zhai Y, Kronebusch PJ, Simon PM, Borisy GG: Microtubule dynamics at the G2/M transition: abrupt breakdown of cytoplasmic microtubules at nuclear envelope breakdown and implications for spindle morphogenesis. J Cell Biol 135:201-214, 1996 (Pubitemid 26337748)